News & Updates
Filter by Specialty:
CPAP reduces tracheal intubation, mortality in adults with COVID-19–related acute hypoxemic respiratory failure
The use of continuous positive airway pressure (CPAP) significantly reduces the risk of tracheal intubation and mortality among hospitalized patients with COVID-19–related acute hypoxemic respiratory failure, according to the RECOVERY-RS* trial.
CPAP reduces tracheal intubation, mortality in adults with COVID-19–related acute hypoxemic respiratory failure
08 Feb 2022
Long-term tolvaptan cost-effective only in CHF patients needing high-dose furosemide
While tolvaptan does not seem to provide a clear economic benefit in all patients with chronic heart failure (CHF), its use in those who require high-dose furosemide may be cost-effective, a recent study has found.
Long-term tolvaptan cost-effective only in CHF patients needing high-dose furosemide
07 Feb 2022
Fungal infections common in COVID-19 patients who require mechanical ventilation
Patients with COVID-19 who received mechanical ventilation while admitted to the intensive care unit (ICU) have an elevated risk of invasive fungal infections (IFIs), according to results of the MYCOVID study from France. Furthermore, patients with COVID-19–associated pulmonary aspergillosis (CAPA) may be at an increased risk for death.
Fungal infections common in COVID-19 patients who require mechanical ventilation
07 Feb 2022
Pandemic interventions help lessen invasive bacterial infections in children
The implementation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic has significantly reduced the incidences of S. pneumoniae and Salmonella spp. among nine major pathogens of invasive bacterial infection (IBI) in children, reports a study.
